These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1309 related items for PubMed ID: 17122091

  • 1. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
    Luque RM, Huang ZH, Shah B, Mazzone T, Kineman RD.
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
    [Abstract] [Full Text] [Related]

  • 2. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S, Peng XD, Frohman LA, Kineman RD.
    Neuroendocrinology; 2005 Mar; 81(6):360-71. PubMed ID: 16244497
    [Abstract] [Full Text] [Related]

  • 3. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM, Gahete MD, Valentine RJ, Kineman RD.
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [Abstract] [Full Text] [Related]

  • 4. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
    Kim E, Sohn S, Lee M, Jung J, Kineman RD, Park S.
    J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
    [Abstract] [Full Text] [Related]

  • 5. Changes in expression of the genes for the leptin receptor and the growth hormone-releasing peptide/ghrelin receptor in the hypothalamic arcuate nucleus with long-term manipulation of adiposity by dietary means.
    Kurose Y, Iqbal J, Rao A, Murata Y, Hasegawa Y, Terashima Y, Kojima M, Kangawa K, Clarke IJ.
    J Neuroendocrinol; 2005 Jun; 17(6):331-40. PubMed ID: 15929739
    [Abstract] [Full Text] [Related]

  • 6. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone.
    Luque RM, Park S, Kineman RD.
    Endocrinology; 2007 Jan; 148(1):300-9. PubMed ID: 17038558
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD, Kamegai J, Frohman LA.
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [Abstract] [Full Text] [Related]

  • 8. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD, Park S, Gadelha MR, Coschigano KT, Kopchick JJ, Frohman LA, Kineman RD.
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [Abstract] [Full Text] [Related]

  • 9. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats.
    Kappeler L, Zizzari P, Grouselle D, Epelbaum J, Bluet-Pajot MT.
    J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
    Kamegai J, Unterman TG, Frohman LA, Kineman RD.
    Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
    [Abstract] [Full Text] [Related]

  • 11. Oestrogen replacement in vivo rescues the dysfunction of pituitary somatotropes in ovariectomised aromatase knockout mice.
    Yan M, Jones ME, Hernandez M, Liu D, Simpson ER, Chen C.
    Neuroendocrinology; 2005 Aug; 81(3):158-66. PubMed ID: 16015026
    [Abstract] [Full Text] [Related]

  • 12. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW, Root MJ.
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [Abstract] [Full Text] [Related]

  • 13. Chronic changes in peripheral growth hormone levels do not affect ghrelin stomach mRNA expression and serum ghrelin levels in three transgenic mouse models.
    Nass R, Liu J, Hellmann P, Coschigano KT, Gaylinn B, Berryman DE, Kopchick JJ, Thorner MO.
    J Neuroendocrinol; 2004 Aug; 16(8):669-75. PubMed ID: 15271059
    [Abstract] [Full Text] [Related]

  • 14. Effects of ghrelin administration on decreased growth hormone status in obese animals.
    Iwakura H, Akamizu T, Ariyasu H, Irako T, Hosoda K, Nakao K, Kangawa K.
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E819-25. PubMed ID: 17595213
    [Abstract] [Full Text] [Related]

  • 15. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function.
    Luque RM, Kineman RD.
    Endocrinology; 2006 Jun; 147(6):2754-63. PubMed ID: 16513828
    [Abstract] [Full Text] [Related]

  • 16. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
    De Gennaro Colonna V, Zoli M, Settembrini BP, Ciceri S, De Marco A, Cella SG, Agnati LF, Muller EE.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
    [Abstract] [Full Text] [Related]

  • 17. Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways.
    Luque RM, Gahete MD, Hochgeschwender U, Kineman RD.
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E395-403. PubMed ID: 16825606
    [Abstract] [Full Text] [Related]

  • 18. Sex-associated differences in the leptin and ghrelin systems related with the induction of hyperphagia under high-fat diet exposure in rats.
    Priego T, Sánchez J, Picó C, Palou A.
    Horm Behav; 2009 Jan; 55(1):33-40. PubMed ID: 18718472
    [Abstract] [Full Text] [Related]

  • 19. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.
    Bédard K, Strecko J, Thériault K, Bédard J, Veyrat-Durebex C, Gaudreau P.
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528
    [Abstract] [Full Text] [Related]

  • 20. Regulation of the pituitary growth hormone-releasing hormone receptor in ageing male and female LOU rats: new insights into healthy ageing.
    Veyrat-Durebex C, Alliot J, Gaudreau P.
    J Neuroendocrinol; 2005 Nov; 17(11):691-700. PubMed ID: 16218997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.